← Back to Search

Behavioral Intervention

Gamma-Music Therapy for Alzheimer's Disease (NUGammaMBI Trial)

N/A

Recruiting

Research Sponsored by Northeastern University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8 weeks

Awards & highlights

NUGammaMBI Trial Summary

This trial studies a novel brain-stimulation tool combining gamma-frequency light & music therapy to delay Alzheimer's progression. Results will help develop an adaptive & rewarding protocol to determine who may benefit most.

Who is the study for?

This trial is for individuals aged 55-90 with mild Alzheimer's Disease, confirmed by specific memory and cognitive tests. They must be medically stable, not have a history of substance or alcohol abuse, and be on steady medication for at least three months. A study partner to provide information about the participant is required.Check my eligibility

What is being tested?

The trial studies a new brain-stimulation tool that combines gamma-frequency lights with self-selected music (gamma-MBI) to see if it can influence brain activity and delay Alzheimer's progression. It aims to create an enjoyable intervention protocol.See study design

What are the potential side effects?

Since this is a non-invasive intervention using music and light stimulation, side effects are expected to be minimal. However, participants will be monitored for any discomfort or adverse reactions during the sessions.

NUGammaMBI Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

EEG activity

Secondary outcome measures

ADAS-Cog 14

NUGammaMBI Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: GammaExperimental Treatment1 Intervention

8-week music-based intervention with gamma lights

Group II: ControlPlacebo Group1 Intervention

8-week music-based intervention with control lights

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Northeastern UniversityLead Sponsor

88 Previous Clinical Trials

61,250 Total Patients Enrolled

Media Library

Gamma-Music Based Intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05984524 — N/A

Alzheimer's Disease Research Study Groups: Gamma, Control

Alzheimer's Disease Clinical Trial 2023: Gamma-Music Based Intervention Highlights & Side Effects. Trial Name: NCT05984524 — N/A

Gamma-Music Based Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05984524 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the trial recruitment include elderly participants?

"This trial has outlined an age range from 50 to 95 for prospective participants."

Answered by AI

To what demographic does the recruitment of this study apply?

"This clinical trial is enrolling a total of 60 individuals with Alzheimer's disease between the ages 50 and 95."

Answered by AI

Are there opportunities for new participants in this experiment?

"The clinical trial is currently recruiting participants, as evidenced by its listing on clincialtrials.gov which was initially posted in July 2022 and recently updated in August 2023."

Answered by AI

How many participants are being recruited for this research?

"Affirmative. Information available through clinicaltrials.gov demonstrates that this trial, published on July 1st 2022 and last updated August 1st 2023, is currently recruiting individuals to take part in the study. 60 people need to join from a single medical facility."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Gamma-Music Based Intervention for Mild Alzheimer's Disease

2022. "Gamma-Music Based Intervention for Mild Alzheimer's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05984524.

All > Alzheimers Disease Boston